Standout Papers

PF00299804, an Irreversible Pan-ERBB Inhibitor, Is Effective in Lung Cancer Models with <i>EGFR<... 2007 2026 2013 2019 591
  1. PF00299804, an Irreversible Pan-ERBB Inhibitor, Is Effective in Lung Cancer Models with EGFR and ERBB2 Mutations that Are Resistant to Gefitinib (2007)
    Jeffrey A. Engelman, Kreshnik Zejnullahu et al. Cancer Research

Immediate Impact

5 by Nobel laureates 40 from Science/Nature 106 standout
Sub-graph 1 of 19

Citing Papers

Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
10 intermediate papers

Works of Eugene Lifshits being referenced

Failure to Induce Apoptosis via BCL-2 Family Proteins Underlies Lack of Efficacy of Combined MEK and PI3K Inhibitors for KRAS-Mutant Lung Cancers
2014
Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition
2009
and 3 more

Author Peers

Author Last Decade Papers Cites
Eugene Lifshits 1543 1555 1618 13 2.6k
Helen Y. Zou 1415 1193 1044 26 2.6k
Dalia Ercan 2145 2027 2344 19 3.6k
Anthony M. D’Amelio 1396 1372 1534 37 2.8k
Rosa Caputo 1042 1345 900 21 2.2k
Leslie B. Lee 1021 780 975 13 2.3k
Danan Li 2284 1559 1001 20 3.2k
Chenghua Xia 1212 946 840 11 1.9k
Barbara Mroczkowski 1502 839 651 24 2.4k
Annetta Krebs 709 1941 1849 8 2.7k
Maria E. Arango 1229 1051 684 19 2.1k

All Works

Loading papers...

Rankless by CCL
2026